PATENT CLAIM ANALYSIS

Application Number: 16088695
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["514", "063000"]

Abstract:
The present invention discloses a silicon incorporated quinoline of formula (I) wherein, X, Y, A, R 1  and R 2  are as described. The present invention further discloses a process for the preparation of silicon incorporated quinolines of formula I; a pharmaceutical composition comprising silicon incorporated quinolines of formula (I) or pharmaceutically acceptable salt thereof. The present invention also discloses a method for treating diseases caused by  Plasmodium falciparum  or other  coccidian  parasites using the silicon incorporated quinolines of formula I or pharmaceutically acceptable salt thereof.

Claim (Index 13):
The process as claimed in  claim 3 , wherein the solvent in step (a), step (b) and step(d) is selected from the group consisting of dichloromethane, toluene, dimethylformamide, acetonitrile, tetrahydrofuran, and diethyl ether.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 97.0
- Lexical Diversity: 1.84906
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14350766', '15752896', '14895710', '11477745', '12142846']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8264819187935734
- 35 USC 102 Novelty (BERT): 0.5312982150429598
- Combined Prediction Score: 0.796963548418512
- Mean Citation Score: 315.892494
- Max Citation Score: 361.45117
- Similarity Product: 275.64630489555475

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test